<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AJMB</journal-id><journal-title-group><journal-title>American Journal of Molecular Biology</journal-title></journal-title-group><issn pub-type="epub">2161-6620</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ajmb.2023.131002</article-id><article-id pub-id-type="publisher-id">AJMB-121985</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Comparative Performance of Microscopy and Nested PCR for the Detection of &lt;i&gt;Cryptosporidium&lt;/i&gt; Species in Patients Living with HIV/AIDS in Abidjan (C&#244;te d’Ivoire)
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>N’Docho</surname><given-names>Assi Fiacre-Tanguy</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gonédélé</surname><given-names>Bi Sery Ernest</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tuo</surname><given-names>Karim</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bialé</surname><given-names>Marina Danielle Datcho-Gouenet Ayaud</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>N’Guessan</surname><given-names>Tiacoh Landry</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Koffi</surname><given-names>Attoungbré Clément</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Koffi</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ako</surname><given-names>Ako Aristide Bérenger</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Vanga</surname><given-names>Bosson Abo Henriette</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Touré</surname><given-names>Offianan André</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Laboratory of Genetics and Species Improvement, Félix Houphou&amp;amp;#235;t-Boigny University, Abidjan, C&amp;amp;#244;te d’Ivoire</addr-line></aff><aff id="aff3"><addr-line>Department of Parasitology Mycology, UFR Pharmaceutical and Biological Sciences, Félix Houphou&amp;amp;#235;t-Boigny University, Abidjan, C&amp;amp;#244;te d’Ivoire</addr-line></aff><aff id="aff1"><addr-line>Department of Parasitology Mycology, Institut Pasteur, Abidjan, C&amp;amp;#244;te d’Ivoire</addr-line></aff><pub-date pub-type="epub"><day>23</day><month>11</month><year>2022</year></pub-date><volume>13</volume><issue>01</issue><fpage>18</fpage><lpage>31</lpage><history><date date-type="received"><day>15,</day>	<month>October</month>	<year>2022</year></date><date date-type="rev-recd"><day>24,</day>	<month>December</month>	<year>2022</year>	</date><date date-type="accepted"><day>27,</day>	<month>December</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <em>Cryptosporidium</em> spp. infection is one of the causes of diarrhea in people living with HIV/AIDS. The objective of this study is to compare the sensitivity of microscopy and molecular biology to determine the prevalence of 
  <em>Cryptosporidium</em> spp. in Patients Living With HIV (PLWH). This is a descriptive cross-sectional study conducted in three care centers for people living with HIV/AIDS in Abidjan. It took place from November 2018 to March 2020. Sociodemographic data were obtained via a questionnaire. Stool and blood samples were collected and analyzed for microscopy and Nested PCR detection of 
  <em>Cryptosporidium</em> spp. Blood samples were analyzed for CD4+ count. A total of 363 stool samples were collected from the three sites. Individuals aged 40 - 50 years (36.52%) were most likely to participate in the study. HIV Type 1 accounted for 86.22% of the study population. The samples collected consisted of 47.65% diarrheal stool. Microscopic examination of the stool yielded a prevalence of 3.86% for 
  <em>Cryptosporidium</em> spp. while the prevalence was 3.96% with molecular identification. No statistically significant difference was observed between these two prevalences (χ
  <sup>2</sup> = 0.26; p = 0.609). CD4+ count was the factor associated with 
  <em>Cryptosporidium</em> spp. infection for both microscopy (OR = 0.887, p = 0.001) and PCR (OR = 0.896, p = 0.001). This study demonstrated that Nested PCR improves the detection of 
  <em>Cryptosporidium</em> spp. in patient diagnosis.
 
</p></abstract><kwd-group><kwd>&lt;i&gt;Cryptosporidium&lt;/i&gt;</kwd><kwd> PCR</kwd><kwd> Microscopy</kwd><kwd> PLHIV</kwd><kwd> C&amp;#244;te D’Ivoire</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Infection caused by Cryptosporidium spp. is one of the most important causes of diarrhea and death associated with diarrhea primarily in infants and immunocompromised individuals [<xref ref-type="bibr" rid="scirp.121985-ref1">1</xref>] . The first human cases of this infection were reported in the 1970s in immunocompromised children and adults [<xref ref-type="bibr" rid="scirp.121985-ref2">2</xref>] . The pathogen responsible for this infection belongs to the genus Cryptosporidium which is a protozoan, obligate intracellular parasite that infects the epithelial cells of the digestive and respiratory tracts of a wide variety of hosts. It is recognized as one of the most important diarrheal pathogens affecting human populations worldwide, particularly in Sub-Saharan Africa [<xref ref-type="bibr" rid="scirp.121985-ref2">2</xref>] . There are 38 recognized species of Cryptosporidium spp. that differ in host specificity and public health importance [<xref ref-type="bibr" rid="scirp.121985-ref3">3</xref>] . Of these, C. hominis and C. parvum are the primary sources of cryptosporidiosis in humans [<xref ref-type="bibr" rid="scirp.121985-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.121985-ref3">3</xref>] . C. hominis is generally associated with human infection while C. parvum is as much related to human infection as it is to the infection of animals, especially young ruminants [<xref ref-type="bibr" rid="scirp.121985-ref2">2</xref>] . More than 20 species have been identified at the molecular level as causing zoonotic cryptosporidiosis in humans [<xref ref-type="bibr" rid="scirp.121985-ref4">4</xref>] . The life cycle of Cryptosporidium alternates between asexual and sexual reproduction in a single host. Sexual recombination results in oocyst production and is therefore essential for parasite transmission, but recombination may also play a role in ongoing host infection [<xref ref-type="bibr" rid="scirp.121985-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.121985-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.121985-ref7">7</xref>] . The diagnosis of these parasitic diseases relies primarily on microscopic examination of stool for many laboratories [<xref ref-type="bibr" rid="scirp.121985-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.121985-ref9">9</xref>] . This diagnosis involves several steps including a fresh direct examination to identify vegetative forms followed by a staining step from the stool concentration pellet to detect parasites in cases of low infestation [<xref ref-type="bibr" rid="scirp.121985-ref10">10</xref>] . However, the process of microscopic identification of intestinal parasites requires a lot of time up to several hours, and careful microscopic observation, which often leads to misdiagnosis [<xref ref-type="bibr" rid="scirp.121985-ref11">11</xref>] . All these steps make it difficult to control cryptosporidiosis. The sensitivity of the infection in humans depends on factors such as the immune status of the subject, which is characteristic of people living with HIV/AIDS [<xref ref-type="bibr" rid="scirp.121985-ref12">12</xref>] . Noting the importance of this parasitosis in PLHIV, the objective of this work was to compare the sensitivity of microscopy with that of molecular biology (Nested PCR) for the determination of the prevalence of Cryptosporidium spp. in PLHIV in Abidjan.</p></sec><sec id="s2"><title>2. Methodology</title><sec id="s2_1"><title>2.1. Framework of the Study</title><p>The study was conducted from November 2018 to March 2020 in three care centers in the Abidjan district, namely the Urban Community Health Training Center (FSUCOM) of Anonkoua-Kout&#233;, the Research and Training Care Center (CePReF) of Yopougon Atti&#233;, and the Pneumo-Physiology Department (PPH) of the University Hospital Center (CHU) of Cocody. This was a cross-sectional, prospective, and descriptive study that involved adult patients managed in each of the 3 study sites who gave informed consent. The three study sites were chosen to be representative of the Abidjan district. Microscopic and molecular analyses of this study were performed at the Parasitology Unit of the Institut Pasteur of C&#244;te d’Ivoire. The immunological analyses were performed in each of the management centers of our study.</p></sec><sec id="s2_2"><title>2.2. Recruitment of Patients Included in the Study</title><p>Before participation in the study, the objectives of the study and the procedures to be followed were explained in simpler and more accessible terms to the patients. Therefore, each patient enrolled in this project gave informed consent by signing a consent form in French according to the patient’s preference. Sociodemographic data (age, gender, place of residence and occupation), clinical data (medical history, HIV status, weight loss, vomiting, abdominal pain and fever) were collected. Some biological data (HIV/AIDS status, CD4/mm<sup>3</sup>) were also collected from all patients included in the study, using a questionnaire administered by the treating physician.</p><p>For patients who reported diarrhea, additional questions were asked to determine the cause of the diarrhea. The physical examination was performed by the attending physician at each management center. At the time of enrollment, each patient was informed about the parasitological analysis of the stool and the assessment of the CD4+ T-cell count to be performed on each purple tube blood sample. A 125-mL sterile stool jar was distributed to each volunteer for collection of their stool samples.</p><p>- Inclusion criteria</p><p>Participants of the study included HIV-infected adults over 18 years of age old, with or without diarrhea. All the participants were monitored in a health care center in Abidjan and their approval written informed consent was obtained.</p><p>- Exclusion criteria</p><p>Persons excluded from the study were those under 18 years of age, patients that were not followed in a treatment center, and those who refused to give their written informed consent.</p></sec><sec id="s2_3"><title>2.3. Sample Collection</title><p>Patient stools collected at each site were sent to the Parasitology Unit of the Institut Pasteur de C&#244;te d’Ivoire (IPCI) and analyzed within two hours of release to identify vegetative forms of intestinal parasites. The collected stool samples were separated into three samples: the first sample was preserved in potassium dichromate (K<sub>2</sub>CR<sub>2</sub>O<sub>7</sub>), the second sample was preserved in sodium chloride (NaCl) 9‰, while the third sample was used for microscopic examinations.</p></sec><sec id="s2_4"><title>2.4. Microscopic Examinations</title><p>Once the stool arrives at the IPCI Parasitology Unit laboratory, it is first examined macroscopically by triturating it with a clean rod to note its consistency (appearance) and the presence of blood or mucus. Once the macroscopic examination is completed, 1 g of stool is taken from different places (3 to 4 places depending on the stool appearance) with a thin clean rod. This sample is diluted in a drop of physiological water (9‰) placed on a slide and covered with a coverslip. This preparation is observed under a light microscope with a 10&#215; and 40&#215; objective respectively (this preparation must not be thick and must be read completely). To better identify some parasites, a drop of Lugol’s was finally placed on the edges of the cover slip and the observation was done at the 40&#215; objective. Finally, the staining by the Zielh Neelsen method was performed in order to highlight the parasite oocysts under the light microscope, first at the &#215;40 objective and then at the &#215;100 magnification.</p><sec id="s2_4_1"><title>2.4.1. Modified Ritchie Method (PBS-Ether Concentration)</title><p>After the fresh direct examination step, the modified Ritchie method was used in order to concentrate the parasite elements that were not detected by direct examination. To do this, approximately 2 g of fresh stool is mixed in 10 mL of PBS solution in a clean container using a clean rod. The mixture is filtered through a small, clean, fine strainer. Eight mL of the filtrate was collected in a 15 mL centrifuge tube (Falcon&#174; tube) to which 4 mL of ether was added using the scale on the 15 mL Falcon&#174; tube. The Falcon&#174; 15 mL tube is capped and shaken to obtain a homogeneous emulsion. This tube is centrifuged at 2000 rpm for 3 minutes to break the emulsion. At the end of this step, the tube shows different phases from top to bottom: an ether phase (fat), a lipophilic residue layer, an aqueous phase (PBS solution) and the pellet. The tube is then emptied abruptly [<xref ref-type="bibr" rid="scirp.121985-ref13">13</xref>] . Using a Pasteur pipette, two to four drops of the centrifugation pellet are spread between slides and coverslips and examined under the microscope for further cysts, eggs and parasites. A part of these pellets obtained is then used for the modified Zielh-Neelsen staining.</p></sec><sec id="s2_4_2"><title>2.4.2. Microscopic Detection by the Modified Zielh-Neelsen Stain</title><p>The pellets obtained by the modified Ritchie method are spread on slides to make thin smears. The smear slides are then air-dried and fixed with methanol for 5 minutes and immersed in Zielh’s phenol fuchsin for 1 hour. After rinsing with water, a decoloration with 2% sulfuric acid solution is performed for 20 seconds. This decoloration is followed by a new water rinse, and then the slides are immersed in a 5% malachite green solution for 5 minutes for counterstaining. After rinsing with water and drying at room temperature, the slides are examined under a light microscope at &#215;40 objective and then at &#215;100 magnification with immersion oil. This simple staining technique has been used to highlight oocysts (resistance form) of coccidia which are sometimes difficult to detect by direct observation.</p></sec></sec><sec id="s2_5"><title>2.5. Molecular Examinations</title><sec id="s2_5_1"><title>2.5.1. Extraction of DNA from Cryptosporidium spp.</title><p>Cryptosporidium spp. DNA was extracted from the pellet obtained by the fresh stool concentration technique (stool enrichment technique). 200 uL of each sample was added to a 2 mL cryotube to undergo heat shock (freeze-thaw step) in order to break down the Cryptosporidium spp. oocyst wall. After the freeze-thaw step, as much of each heat shocked pellet as possible was transferred to the Promega Extraction Kit columns. This kit was used to extract cryptosporidia DNA following the manufacturer’s protocol. At the end of the extraction, 300 uL of DNA eluate was obtained.</p></sec><sec id="s2_5_2"><title>2.5.2. Nested PCR of COWP Gene</title><p>During the study, a portion of the gene coding for the Cryptosporidium spp. wall protein was targeted. This hypervariable and highly polymorphic region was subjected to Nested PCR [<xref ref-type="bibr" rid="scirp.121985-ref14">14</xref>] . For this purpose, two pairs of primers targeting the COWP gene were used: The first primer pair Oocry 3 (5’-AGA TTA ACA GAA TGC CCA CCA GGT A-3’) and Oocry 4 (5’-CCA TGA TGA TGT CCT GGA TTT TGT A-3’) was followed by the second pair of primers Oocry1 (5’-CCT GGA TAT CTC GAC AAT-3’) and Oocry 2 (5’-GCG AAC TAA TCG ATC TCT CT-3’). The reaction medium for the first PCR was composed of 5 &#181;L of DNA extract, 1 &#181;L of each Oocry 3/Oocry 4 primer concentrated to 10 &#181;M of each, 5 &#181;L of SolisBioDyne HOT FIREPolBlend Master Mix Ready to Load and 13 &#181;L of sterile water to reach a total volume of 25 &#181;L. The second PCR reaction medium is the same except for 2 &#181;L of the first PCR amplicon and 16 &#181;L of sterile water to be added to make a total volume of 25 &#181;L. The amplification programs of the first and second PCR are identical, except for the number of cycles of the second PCR which is increased from 30 to 40: denaturation of the DNA for 10 min at 95˚C followed by 30 cycles of 95˚C for 30 s, 52˚C for 1 min and 72˚C for 1 min and finally 7 min of elongation. The program for the second PCR was the same except that the number of cycles was increased from 30 to 40. The amplified fragments were revealed on a 1.5% agarose gel by electrophoresis and observed using Biorad GelDoc Imager.</p><p>The COWP gene targeted by the two primer pairs through Nested PCR, revealed fragments of 640 base pairs corresponding to the genus Cryptosporidium.</p></sec></sec><sec id="s2_6"><title>2.6. Consent and Ethics Approval</title><p>This study was approved by the National Ethics Committee for Life Sciences and Health (CNESVS) of C&#244;te d’Ivoire. All patients were informed of the objectives of the study protocol and an informed consent form was presented to them to obtain their agreement before the collection of stool and blood samples.</p></sec><sec id="s2_7"><title>2.7. Statistical Analysis</title><p>R software (version R x64 3.6.0 and R i386 3.6.0) was used for the analyses. Prevalence of infection is the proportion of positive samples out of all tested samples. Prevalence of infection was compared with sex and age group using the chi-square test or Ficher’s exact test (when at least one cell was less than 5).</p><p>The sensitivity of a diagnostic technique is the ability of the method to correctly identify the presence of a parasitic infection.</p><p>The specificity of a diagnostic technique is a measure of the performance of the test when used on negative individuals.</p><p>Sensibility ( % ) = Numberoftruepositivecases Numberoftruepositivecases + Numberoffalsenegativecases &#215; 100</p><p>Specificity ( % ) = Numberoftruenegative   cases Numberoftruenegativecases + Numberoffalsepositivecases &#215; 100</p><p>Cohen’s kappa coefficient (ƙ) assesses the degree of agreement between diagnostic techniques and uses the 2 &#215; 2 contingency table. The statistical coefficient (ƙ) was used to determine the strength of agreement based on the following criteria:</p><p>—&lt;0 = no agreement;</p><p>—0 - 0.20 = poor agreement;</p><p>—0.21 - 0.40 = average agreement;</p><p>—0.41 - 0.60 = moderate agreement;</p><p>—0.61 - 0.80 = considerable agreement;</p><p>—0.81 - 1 = near perfect agreement.</p><p>P-values less than 0.05% and 95% confidence intervals were considered statistically significant associations.</p><p>Logistic regression was used to determine factors associated with Cryptosporidium spp. using R software (versions Ri3864.0.0.0). For this purpose, the association between Cryptosporidium spp. infections was defined as the independent variable.</p><p>The dependent variables were analyzed using univariate analysis and the strength of each association was measured by an Odds Ratio (OR). All variables with a minimum p-value criterion (p ≤ 0.2) were specified and included in the multivariate analysis at a 95% Confidence Interval (CI). A p-value ≤ 0.05 was considered statistically significant.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Socio-Demographic Description of the Study Population</title><p>The parasitological survey was conducted on 363 HIV-infected patients of whom 114 (31.40%) were men [95% CI 37 - 47] and 249 (68.59%) were women [95% CI 52 - 62].</p><p>The mean age of the participants was 44.87 years with extremes ranging from 18 years to 72 years (<xref ref-type="table" rid="table1">Table 1</xref>). The age groups of 40 - 50 and 51 - 61 years were the most represented with respectively 37.74% and 27.82% of the studied population. Patients of 40 - 50 years (36.52%) old were the most numerous to participate in the study. However, the lowest participation was observed in adults over</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Some socio-demographic characteristics of the study population</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle"  colspan="2"  >Study population</th></tr></thead><tr><td align="center" valign="middle" >Sex</td><td align="center" valign="middle" >N</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >114</td><td align="center" valign="middle" >31.404</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >249</td><td align="center" valign="middle" >68.595</td></tr><tr><td align="center" valign="middle" >Age range</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >18 - 28</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >7.438</td></tr><tr><td align="center" valign="middle" >29 - 39</td><td align="center" valign="middle" >78</td><td align="center" valign="middle" >21.76</td></tr><tr><td align="center" valign="middle" >40 - 50</td><td align="center" valign="middle" >137</td><td align="center" valign="middle" >37.741</td></tr><tr><td align="center" valign="middle" >51 - 61</td><td align="center" valign="middle" >101</td><td align="center" valign="middle" >27.823</td></tr><tr><td align="center" valign="middle" >More than 61</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >4.95</td></tr><tr><td align="center" valign="middle" >ND</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.27</td></tr><tr><td align="center" valign="middle" >Profession</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Pupil</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.8264</td></tr><tr><td align="center" valign="middle" >Student</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >1.928</td></tr><tr><td align="center" valign="middle" >Liberal function</td><td align="center" valign="middle" >244</td><td align="center" valign="middle" >67.217</td></tr><tr><td align="center" valign="middle" >Public servant</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >7.98</td></tr><tr><td align="center" valign="middle" >Unemployed</td><td align="center" valign="middle" >80</td><td align="center" valign="middle" >22.038</td></tr><tr><td align="center" valign="middle" >HIV type</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >HIV 1</td><td align="center" valign="middle" >313</td><td align="center" valign="middle" >86.225</td></tr><tr><td align="center" valign="middle" >HIV 1 &amp; 2</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >2.2038</td></tr><tr><td align="center" valign="middle" >HIV 2</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >11.570</td></tr><tr><td align="center" valign="middle" >ARV treatment</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >337</td><td align="center" valign="middle" >92.83</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >5.785</td></tr><tr><td align="center" valign="middle" >ND</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >1.377</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >363</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><p>Note: ND: Not defined.</p><p>61 years old (2.20%).</p><p>Several types of HIV were identified in this study in which HIV Type 1 represented 86.22% of the study population.</p><p>The liberal profession (67.21%) was predominant among all the professions in the study population. Professional occupation (67.21%) was predominant among all occupations in the study population (<xref ref-type="table" rid="table1">Table 1</xref>). The majority (92.83%) of the PLHIV in the study were on ARV treatment (<xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s3_2"><title>3.2. Prevalence of Cryptosporidium spp. Infection by Microscopy</title><p>Direct examination of samples by Zielh Nelseen staining revealed 14 samples positive for Cryptosporidium spp. (<xref ref-type="fig" rid="fig1">Figure 1</xref>) out of 363 samples, representing</p><p>3.86%. Only the genus of the parasite has been identified.</p><p>A total of 14 of 363 stool samples examined microscopically contained Cryptosporidium spp. oocysts, for a prevalence rate of 3.86%. Males (4.38%) were more parasitized than females (3.61%) (<xref ref-type="fig" rid="fig2">Figure 2</xref>). No statistically significant difference was observed (p-value = 0.962). The 29 - 39 age group had the highest prevalence rate (8.97%) (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p></sec><sec id="s3_3"><title>3.3. Prevalence of Cryptosporidium spp. Infection by Molecular Biology (PCR)</title><p>The COWP gene targeted by the two primer pairs by Nested PCR revealed fragments of 640 base pairs corresponding to the genus Cryptosporidium. Analysis of the Nested PCR (molecular biology) results identified 18 samples positive for Cryptosporidium spp. (<xref ref-type="fig" rid="fig4">Figure 4</xref>) out of 363 samples analyzed, a proportion of 4.95%. This analysis technique was used to identify 18 egg-infested samples of the genus Cryptosporidium.</p><p><xref ref-type="fig" rid="fig5">Figure 5</xref> shows that the prevalence of Cryptosporidiosis infection in females (5.22%) is higher than in males (4.38%). However, this difference is not significant (χ<sup>2</sup> = 1.3415, p = 0.247). In terms of age, the 29 - 39 age group had the highest prevalence rate (10.25%) (<xref ref-type="fig" rid="fig6">Figure 6</xref>). However, statistical analysis showed that there was significant variation between age groups (χ<sup>2</sup> = 43.0411, p = 0.00481).</p></sec><sec id="s3_4"><title>3.4. Performance of Nested PCR and Microscopy in the Detection of Cryptosporidium spp.</title><p>The observed sensitivity rate showed that PCR is more sensitive than microscopy,</p><p>but no statistically significant difference was observed (p-value = 0.24). A Cohen’s kappa of 0.17 was obtained between the diagnostic techniques, reflecting poor agreement between these two diagnostic techniques for the identification of Cryptosporidium spp. (<xref ref-type="table" rid="table2">Table 2</xref>).</p></sec><sec id="s3_5"><title>3.5. Factors Associated with Cryptosporidium Relative to the Sex, Occupation, Type of HIV, ARV Treatment, Previous Diarrheal and CD4 Count by Test Type</title><p>Concerning the main variables identified, namely gender, age, occupation, only CD4 count was the factor associated with Cryptosporidium spp. infection for both microscopy (OR = 0.887, p = 0.001) and PCR (OR = 0.896, p = 0.001) (<xref ref-type="table" rid="table3">Table 3</xref>).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Comparative sensitivity of microscopy techniques and Nested PCR for the detection of Cryptosporidium spp. and agreement between Nested PCR and microscopy techniques for the detection of Cryptosporidium spp</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Method</th><th align="center" valign="middle" >Numberof sample examined</th><th align="center" valign="middle" >Numberof positive detected</th><th align="center" valign="middle" >Sensitivity (%)</th><th align="center" valign="middle" >Specificity (%)</th><th align="center" valign="middle" >Strain discrimination</th></tr></thead><tr><td align="center" valign="middle" >Nested PCR</td><td align="center" valign="middle" >363</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >Specificity: 0.24</td></tr><tr><td align="center" valign="middle" >Microscopy</td><td align="center" valign="middle" >363</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >77.77</td><td align="center" valign="middle" >97.21</td><td align="center" valign="middle" >Sensitivity: 0.95</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  >Microscopy</td><td align="center" valign="middle"  colspan="3"  >Kappa Cohen</td></tr><tr><td align="center" valign="middle" >PCR</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >N&#233;gative</td><td align="center" valign="middle"  colspan="3"  ></td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >4</td><td align="center" valign="middle"  colspan="3"   rowspan="3"  >ƙ = 0.17</td></tr><tr><td align="center" valign="middle" >N&#233;gative</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >4</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Factors associated with Cryptosporidium spp. according to the type of test</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="10"  >Cryptosporidium spp. n (%)</th></tr></thead><tr><td align="center" valign="middle" >Explanatory variable</td><td align="center" valign="middle"  colspan="5"  >Microscopie</td><td align="center" valign="middle"  colspan="5"  >PCR</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  >Univariate analyses</td><td align="center" valign="middle"  colspan="2"  >Multivariate analyses</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  >Univariate analyses</td><td align="center" valign="middle"  colspan="2"  >Multivariate analyses</td></tr><tr><td align="center" valign="middle" >Sex</td><td align="center" valign="middle" >n (%)</td><td align="center" valign="middle" >OR</td><td align="center" valign="middle" >P</td><td align="center" valign="middle" >OR</td><td align="center" valign="middle" >P</td><td align="center" valign="middle" >n (%)</td><td align="center" valign="middle" >OR</td><td align="center" valign="middle" >P</td><td align="center" valign="middle" >OR</td><td align="center" valign="middle" >P</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >5 (1.38)</td><td align="center" valign="middle"  rowspan="2"  >1.22</td><td align="center" valign="middle"  rowspan="2"  >0.72</td><td align="center" valign="middle"  rowspan="2"  >NA</td><td align="center" valign="middle"  rowspan="2"  >NA</td><td align="center" valign="middle" >13 (3.58)</td><td align="center" valign="middle"  rowspan="2"  >_</td><td align="center" valign="middle"  rowspan="2"  >0.55</td><td align="center" valign="middle"  rowspan="2"  >NA</td><td align="center" valign="middle"  rowspan="2"  >NA</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >9 (2.48)</td><td align="center" valign="middle" >5 (1.37)</td></tr><tr><td align="center" valign="middle" >Occupation</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Public servant</td><td align="center" valign="middle" >3 (7.31)</td><td align="center" valign="middle"  rowspan="3"  >_</td><td align="center" valign="middle"  rowspan="3"  >0.99</td><td align="center" valign="middle"  rowspan="3"  >NA</td><td align="center" valign="middle"  rowspan="3"  >NA</td><td align="center" valign="middle" >5 (1.37)</td><td align="center" valign="middle"  rowspan="3"  >_</td><td align="center" valign="middle"  rowspan="3"  >1</td><td align="center" valign="middle"  rowspan="3"  >NA</td><td align="center" valign="middle"  rowspan="3"  >NA</td></tr><tr><td align="center" valign="middle" >No public servant</td><td align="center" valign="middle" >11 (3.52)</td><td align="center" valign="middle" >13 (3.58)</td></tr><tr><td align="center" valign="middle" >Learner</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >0 (0)</td></tr><tr><td align="center" valign="middle" >Type of HIV</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >HIV 1</td><td align="center" valign="middle" >13 (3.58)</td><td align="center" valign="middle"  rowspan="3"  >0.46</td><td align="center" valign="middle"  rowspan="3"  >0.43</td><td align="center" valign="middle"  rowspan="3"  >NA</td><td align="center" valign="middle"  rowspan="3"  >NA</td><td align="center" valign="middle" >15 (4.13)</td><td align="center" valign="middle"  rowspan="3"  >1.95</td><td align="center" valign="middle"  rowspan="3"  >0.48</td><td align="center" valign="middle"  rowspan="3"  >NA</td><td align="center" valign="middle"  rowspan="3"  >NA</td></tr><tr><td align="center" valign="middle" >HIV 2</td><td align="center" valign="middle" >1 (0.28)</td><td align="center" valign="middle" >3 (0.82)</td></tr><tr><td align="center" valign="middle" >HIV 1 &amp; 2</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >0 (0)</td></tr><tr><td align="center" valign="middle" >ARV treatment</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >10 (2.75)</td><td align="center" valign="middle"  rowspan="2"  >_</td><td align="center" valign="middle"  rowspan="2"  >0.55</td><td align="center" valign="middle"  rowspan="2"  >NA</td><td align="center" valign="middle"  rowspan="2"  >NA</td><td align="center" valign="middle" >14 (3.85)</td><td align="center" valign="middle"  rowspan="2"  >NA</td><td align="center" valign="middle"  rowspan="2"  >NA</td><td align="center" valign="middle"  rowspan="2"  >NA</td><td align="center" valign="middle"  rowspan="2"  >NA</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >4 (1.10)</td><td align="center" valign="middle" >4 (1.10)</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Previous diarrheal</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >11 (3.52)</td><td align="center" valign="middle"  rowspan="2"  >1.87</td><td align="center" valign="middle"  rowspan="2"  >0.40</td><td align="center" valign="middle"  rowspan="2"  >NA</td><td align="center" valign="middle"  rowspan="2"  >NA</td><td align="center" valign="middle" >1 (0.41)</td><td align="center" valign="middle"  rowspan="2"  >0.246</td><td align="center" valign="middle"  rowspan="2"  >0.30</td><td align="center" valign="middle"  rowspan="2"  >NA</td><td align="center" valign="middle"  rowspan="2"  >NA</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >3 (7.31)</td><td align="center" valign="middle" >2 (1.68)</td></tr><tr><td align="center" valign="middle" >CD4 count</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;200</td><td align="center" valign="middle" >12 (3.30)</td><td align="center" valign="middle"  rowspan="3"  >0.04</td><td align="center" valign="middle"  rowspan="3"  >0.0001*</td><td align="center" valign="middle"  rowspan="3"  >0.887</td><td align="center" valign="middle"  rowspan="3"  >0.001**</td><td align="center" valign="middle" >13 (3.58)</td><td align="center" valign="middle"  rowspan="3"  >0.041</td><td align="center" valign="middle"  rowspan="3"  >0.0001</td><td align="center" valign="middle"  rowspan="3"  >0.89</td><td align="center" valign="middle"  rowspan="3"  >0.001**</td></tr><tr><td align="center" valign="middle" >200 - 500</td><td align="center" valign="middle" >1 (0.28)</td><td align="center" valign="middle" >3 (0.82)</td></tr><tr><td align="center" valign="middle" >≥500</td><td align="center" valign="middle" >1 (0.28)</td><td align="center" valign="middle" >2 (0.55)</td></tr></tbody></table></table-wrap><p>Note: NA: Not Applicable; P: p-value; OR: Odds Ratio.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>The study revealed a prevalence rate of 3.86% of Cryptosporidium spp. for microscopy versus 4.95% for molecular biology (Nestd PCR). However, this difference was not statistically significant (p-value ≥ 0.005). These results are similar to those of Chalmers and collaborators [<xref ref-type="bibr" rid="scirp.121985-ref15">15</xref>] , who obtained a lower prevalence of Cryptosporidium spp. by microscopy compared to molecular biology. In the present study, based on microscopy observation, males (4.38%) were more infested than females (3.61%). In contrast, Nested PCR analysis indicated that females (5.22%) were more infested than males (4.38%). No significant difference was observed between sex either for microscopy (p-value = 0.962) or for Nested PCR (p-value = 0.247). The results of the analysis of the relationship between sex and parasitemia of our work are similar to these of Kassi and collaborators [<xref ref-type="bibr" rid="scirp.121985-ref16">16</xref>] obtained among people living with HIV at the CHU de Treichville in 2017 in Abidjan. Similar results were also reported by Wumba and collaborators [<xref ref-type="bibr" rid="scirp.121985-ref17">17</xref>] in the Democratic Republic of Congo among PLHIV, where they observed the absence of a significant association between gender and the identified parasite (p-value = 0.46). The results of this study showed greater sensitivity and specificity of the Nested PCR method compared to microscopy, but no statistically significant difference was observed in terms of sensitivity (p-value = 0.24) or specificity (p-value = 0.95). Similar studies on the comparison of cryptosporidiosis diagnostic tests conducted in the United Kingdom [<xref ref-type="bibr" rid="scirp.121985-ref15">15</xref>] and Ethiopia [<xref ref-type="bibr" rid="scirp.121985-ref18">18</xref>] also showed the lower sensitivity of microscopy procedures used to diagnose Cryptospordium spp.</p><p>According to the results obtained, assays through PCR were very sensitive and specific techniques for the detection of Cryptosporidium spp. genes. These results are similar to those of Bath and collaborators [<xref ref-type="bibr" rid="scirp.121985-ref11">11</xref>] , where they compared Nested PCR and microscopy for the detection of cryptosporidiosis in veal calves.</p><p>A Cohen’s kappa of approximately 0.17 was obtained between the diagnostic tests. This reflects poor agreement between these two diagnostic tests for identification of Cryptosporidium spp. This value obtained could be explained by the fact that Nested PCR analysis is a more sensitive technique for the identification of Cryptosporidium spp. eggs than microscopic analysis. This finding was also highlighted by Chalmers and collaborators in the UK [<xref ref-type="bibr" rid="scirp.121985-ref15">15</xref>] and Hailu and collaborators [<xref ref-type="bibr" rid="scirp.121985-ref18">18</xref>] in Ethiopia.</p><p>The study showed a correlation between CD4 count and the presence of Cryptosporidium spp. (χ<sup>2</sup> = 29.968; p-value = 0.0001; r = −0.2438). This could be explained by the fact that a decrease in CD4 count in the organism predisposes to the occurrence of opportunistic diseases such as Cryptosporidium in people living with HIV. These results are similar to those of Bissong and collaborators [<xref ref-type="bibr" rid="scirp.121985-ref19">19</xref>] who showed a correlation between opportunistic parasites and CD4 count, specifically for Cryptosporidium parvum in people living with HIV/AIDS at the Bamenda Regional Hospital in Cameroon.</p></sec><sec id="s5"><title>5. Conclusion</title><p>This study showed a correlation between the presence of Cryptosporidium spp. and CD4 count in both diagnostic techniques (Microscopic analysis (OR = 0.887; p-value = 0.001) and Nested PCR (OR = 0.896; p-value = 0.001)). Nested PCR has proven to be more sensitive than microscopic techniques. Better management of PLWH relies on a good diagnosis of opportunistic diseases such as Cryptosporidiosis. It is imperative to use PCR methods to better diagnose Cryptosporidiosis in order to better manage people living with HIV/AIDS.</p></sec><sec id="s6"><title>Acknowledgements</title><p>We would like to thank the various partner organizations that enabled us to carry out this study as well as the technicians of the Institute Pasteur of C&#244;te d’Ivoire.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Fiacre-Tanguy, N.A., Ernest, G.B.S., Karim, T., Ayaud, B.M.D.D.-G., Landry, N.T., Cl&#233;ment, K.A., David, K., B&#233;renger, A.A.A., Henriette, V.B.A. and Andr&#233;, T.O. (2023) Comparative Performance of Microscopy and Nested PCR for the Detection of Cryptosporidium Species in Patients Living with HIV/AIDS in Abidjan (C&#244;te d’Ivoire). American Journal of Molecular Biology, 13, 18-31. https://doi.org/10.4236/ajmb.2023.131002</p></sec></body><back><ref-list><title>References</title><ref id="scirp.121985-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Khalil, I.A., Troeger, C., Rao, P.C., Blacker, B.F., Brown, A., Brewer, T.G., Colombara, D.V., DeHostos, E.L., Engmann, C., Guerrant, R.L., et al. (2018) Morbidity, Mortality, and Long-Term Consequences Associated with Diarrhea from Cryptosporidium Infection in Children Younger than 5 Years: A Meta-Analyses Study. The Lancet Global Health, 6, e758-e768. https://doi.org/10.1016/S2214-109X(18)30283-3</mixed-citation></ref><ref id="scirp.121985-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Shirley, D.A., Moonah, S.N. and Kotloff, K.L. (2012) Burden of Disease from Cryptosporidiosis. The Open Infectious Diseases, 25, 555-563.  
https://doi.org/10.1097/QCO.0b013e328357e569</mixed-citation></ref><ref id="scirp.121985-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Feng, Y., Ryan, U.M. and Xiao, L. (2018) Genetic Diversity and Population Structure of Cryptosporidium. Trends in Parasitology, 34, 997-1011.  
https://doi.org/10.1016/j.pt.2018.07.009</mixed-citation></ref><ref id="scirp.121985-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Xiao, L. and Feng, Y. (2017) Molecular Epidemiologic Tools for Waterborne Pathogens Cryptosporidium spp. and Giardia duodenalis. Food and Waterborne Parasitology, 8, 14-32. https://doi.org/10.1016/j.fawpar.2017.09.002</mixed-citation></ref><ref id="scirp.121985-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Gilchrist, C.A., Cotton, J.A., Burkey, C., Arju, T., Gilmartin, A., Lin, Y., Ahmed, E., Steiner, K., Alam, M., Ahmed, S., et al. (2018) Genetic Diversity of Cryptosporidium hominis in a Bangladeshi Community as Revealed by Whole Genome Sequencing. The Journal of Infectious Diseases, 218, 259-264.  
https://doi.org/10.1093/infdis/jiy121</mixed-citation></ref><ref id="scirp.121985-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Korpe, P.S., Gilchrist, C., Burkey, C., Taniuchi, M., Ahmed, E., Madan, V., Castillo, R., Ahmed, S., Arju, T., Alam, M., et al. (2019) Case-Control Study of Cryptosporidium Transmission in Bangladeshi Households. Clinical Infectious Diseases, 68, 1073-1079.  
https://doi.org/10.1093/cid/ciy593</mixed-citation></ref><ref id="scirp.121985-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Sannella, A.R., Suputtamongkol, Y., Wongsawat, E. and Caccio, S.M. (2019) A Retrospective Molecular Study of Cryptosporidium Species and Genotypes in HIV-Infected Patients from Thailand. Parasites &amp; Vectors, 12, Article No. 91.  
https://doi.org/10.1186/s13071-019-3348-4</mixed-citation></ref><ref id="scirp.121985-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, H.S., Zhao, W., Guo, Y., Li, N., Zheng, Z., Zhang, L., Kvac, M., Xiao, L. and Feng, Y. (2020) Population Structure and Geographical Segregation of Cryptosporidium parvum IId Subtypes in Cattle in China. Parasites &amp; Vectors, 13, Article No. 425. https://doi.org/10.1186/s13071-020-04303-y</mixed-citation></ref><ref id="scirp.121985-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Ramo, A., Monteagudo, L.V., Del Cacho, E., Sanchez-Acedo, C. and Quilez, J. (2016) Intra-Species Genetic Diversity and Clonal Structure of Cryptosporidium parvum in Sheep Farms in a Confined Geographical Area in Northeastern Spain. PLOS ONE, 11, e0155336. https://doi.org/10.1371/journal.pone.0155336</mixed-citation></ref><ref id="scirp.121985-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Truant, A.L., Elliot, S.H., Kelly, M.T. and Smith, J.H. (1981) Comparison of Formalin-Ethyl Ether Sedimentation, Formalin-Ethyl Acetate Sedimentation, and Zinc Sulfate Flotation Techniques for Detection of Intestinal Parasites. Journal of Clinical Microbiology, 13, 882-884. https://doi.org/10.1128/jcm.13.5.882-884.1981</mixed-citation></ref><ref id="scirp.121985-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Bhat, S.A., et al. (2014) Comparison of Nested PCR and Microscopy for the Detection of Cryptosporidiosis in Bovine Calves. Journal of Parasitology Disease, 38, 101-105.  
https://doi.org/10.1007/s12639-012-0201-5</mixed-citation></ref><ref id="scirp.121985-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Areeshi, M., Dove, W., Papaventsis, D., Gatei, W., Combe, P., Grosjean, P., Leatherbarrow, H. and Hart, C.A. (2008) Cryptosporidium Species Causing Acute Diarrhoea in Children in Antananarivo, Madagascar. Annals of Tropical Medicine and Parasitology, 4, 309-315. https://doi.org/10.1179/136485908X278793</mixed-citation></ref><ref id="scirp.121985-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Bailenger, J. and Carcenac, F. (1974) Répercussions du parasitisme par Strongyloides ratti sur la sécretion des gluco-cortico-steroides chez le rat [Repercussions of Parasitism by Strongyloides ratti on the Secretion of the Gluco-Cortico Steroids in the Rat. International Journal for Parasitology, 4, 307-310.  
https://doi.org/10.1016/0020-7519(74)90086-1</mixed-citation></ref><ref id="scirp.121985-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Spano, F., Putignani, L., McLauchlin, J., Casemore, D.P. and Andrea, C. (1997) PCR-RFLP Analysis of the Cryptosporidium Oocyst Wall Protein (COWP) Gene Discriminates between C. wrairi and C. parvum, and between C. parvum Isolates of Human and Animal Origin. FEMS Microbiology Letters, 150, 209-217.  
https://doi.org/10.1016/S0378-1097(97)00115-8</mixed-citation></ref><ref id="scirp.121985-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Chalmers, R.M., Campbell, B.M., Crouch, N., Charlett, A. and Davies, A.P. (20111) Comparison of the Diagnostic Sensitivity and Specificity of Seven Cryptosporidium Tests Used in the UK. Journal of Medical Microbiology, 60, 1598-1604.  
https://doi.org/10.1099/jmm.0.034181-0</mixed-citation></ref><ref id="scirp.121985-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Kassi, K.F., Kiki-Barro, P.C.M., Konaté, A., Angora, K.E., Vanga-Bosson, Ah., Bedia, A.V., Miezan, S., Kone, E., Djohan, V., Yavo, W. and Menan, E. (2017) Hospital Prevalence of Cryptosporidiosis and Intestinal Microsporidiosis in PLWH from 2011 to 2015. Revintscméd-RISM, 4, 363-368.</mixed-citation></ref><ref id="scirp.121985-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Wumba, R., Enache-Angoulvant, A., Develoux, M., Mulumba, A., Mulumba, P.M., et al. (2007) Prevalence of Parasitic Digestive Opportunistic Infections in Kinshasa (Democratic Republic of Congo), Results of a Preliminary Survey of 50 Patients with AIDS. Medecine Tropical, 67, 145-148.</mixed-citation></ref><ref id="scirp.121985-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Hailu, A.W., Degarege, A., Adamu, H., Costa, D., Villier, V., Mouhajir, A., et al. (2021) Molecular Characterisation of Cryptosporidium spp. from Humans in Ethiopia. PLOS ONE, 16, e0253186. https://doi.org/10.1371/journal.pone.0253186</mixed-citation></ref><ref id="scirp.121985-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Bissong, M.E.A., Nguemain, N.F., Ng’awono, T. and. Kamga, F.H.L. (2015) Intestinal Parasite Burden in HIV/AIDS Patients Attending Bamenda Regional Hospital in Cameroon. African Journal of Clinical and Experimental Microbiology, 3, 97-103.  
https://doi.org/10.4314/ajcem.v16i3.3</mixed-citation></ref></ref-list></back></article>